AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Utah Medical Products, Inc.
Video analysis: UTMD
All videosNo video analysis for this stock yet. Request one from our team.
News: UTMD
BlackRock Inc. Invests $14.05 Million in Utah Medical Products, Inc. $UTMD
BlackRock Inc. acquired a new position in shares of Utah Medical Products, Inc. (NASDAQ: UTMD) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 203,690 shares of the medical instruments supplier's stock, valued at approximately $14,051,000. BlackRock Inc. owned 6.41% of Utah
Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK
SALT LAKE CITY, UT / ACCESS Newswire / August 31, 2026 / Femcare Ltd. ("Femcare"), a wholly-owned subsidiary of Utah Medical Products, Inc. (Nasdaq:UTMD), announces that it has purchased the entire ordinary share capital of Orion Medical Supplies Ltd ("ORION") of the United Kingdom.
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESS Newswire / August 4, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on October 5, 2026 to stockholders of record at the close of business on September 17, 2026. This is a 1.6% increase over the dividend declared in the same quarter of the prior year.
Utah Medical's Q2 Earnings Down Y/Y Due to Customer Losses
UTMD's Q2 earnings per share decline 10.1% year over year, while quarterly revenues face pressure from lost customers and slower new business growth.
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2026
SALT LAKE CITY, UT / ACCESS Newswire / July 23, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) reports second calendar quarter (2Q) and first half (1H) 2026 financial results with a continued decline in overall revenues in comparison to the same time periods in 2025. Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros.
Similar companies
-
Nyxoah S.A.
NYXH
·
NASDAQ
Compare
-
OraSure Technologies, Inc.
OSUR
·
NASDAQ
Compare
-
KORU Medical Systems, Inc.
KRMD
·
NASDAQ
Compare
-
InfuSystem Holdings, Inc.
INFU
·
New York Stock Exchange Arca
Compare
-
Neuronetics, Inc.
STIM
·
NASDAQ
Compare
-
Perspective Therapeutics, Inc.
CATX
·
New York Stock Exchange Arca
Compare